Bruce Japsen

Health insurer Centene announced a Q2 net income of $1.09 billion, a dramatic swing from a $253 million loss last year. This strong performance is attributed to improved management of rising medical costs, with its health benefits ratio dropping to 89.6% from 93%. Executives subsequently increased full-year earnings guidance for 2026, citing a better handle on the company's cost structure. CEO Sarah M. London highlighted the positive momentum towards restoring profitability and shareholder value. Despite a significant enrollment decline in Obamacare marketplace plans, from 5.8 million to 3.5 million, premium and service revenues still grew 4% to $44.4 billion, bolstered by rate increases and risk adjustments.

Centene headquarters in the St. Louis suburb of Clayton, Mo.Centene

Humana reported second-quarter net income of $694 million, with revenue jumping to $40.8 billion, largely due to a significant increase in Medicare Advantage enrollees. The company stated that costs of care for its Medicare Advantage plans aligned with expectations, despite an industry-wide struggle with rising medical expenses. Humana's benefit ratio, representing medical costs as a percentage of premium revenue, stood at 91.2%, consistent with management's guidance. While still high compared to industry preferences, this reflects controlled medical and pharmacy cost trends, with some favorability in inpatient care for members with value-based providers. CEO Jim Rechtin affirmed the company is on track, attributing success to clinical care and operational efficiency, even as competitors scale back MA offerings.

Amidst the health insurance industry's struggle with elevated medical costs, The Cigna Group reported robust second-quarter net income of nearly $1.7 billion and a 7% revenue increase to $71.7 billion. This strong showing marks new CEO Brian Evanko's first report. Cigna's medical cost ratio climbed to 84.5%, primarily due to prior year risk adjustments in individual plans, but remains lower than some competitors grappling with higher ratios, especially in government-subsidized markets. Despite these sector-wide pressures, Cigna confidently raised its 2026 earnings outlook to at least $30.45 per share. Evanko emphasized leveraging technology and AI to improve customer experiences and reduce costs.

Alignment Healthcare's second-quarter net income more than doubled to $36.6 million, largely due to easing medical costs for its Medicare Advantage members. The company's crucial medical benefit ratio, representing the percentage of premium revenue spent on medical costs, dropped to 86%, marking the second consecutive quarter of improvement amidst an industry facing high expenses. Total revenue climbed over 31% to $1.3 billion, bolstered by a 31% surge in Medicare Advantage plan membership, now at 294,100. CEO John Kao highlighted the strength of their platform and investments in clinical models and AI, asserting that better outcomes and profitable growth are achievable.

Major Medicare Advantage insurer Humana is withdrawing from certain markets for 2027, a move expected to be mirrored by other companies facing rising medical expenses. This trend could displace hundreds of thousands of older adults, compelling them to select new Medicare Advantage plans. Insurers are strategically reevaluating unprofitable regions, prioritizing markets where they can offer robust benefit packages at competitive prices through established doctor and hospital networks. Humana's "targeted plan exits" are projected to affect approximately 600,000 members, though the company aims to re-enroll a significant portion. These changes, part of the annual bid process, will become clear to seniors during the open enrollment period from October 15 to December 7.

Physicians are facing escalating labor costs, adding to the strain of reimbursement cuts. An MGMA analysis shows pay for roles like receptionists, LPNs, and medical assistants has jumped 15-30% over five years. This surge is fueled by medical groups utilizing more allied health professionals to address care gaps amid a projected physician shortage of up to 86,000 by 2036. Despite slowing wage growth, recruiting and retaining staff remains challenging, intensifying pressure on healthcare teams. Practices are now adopting comprehensive strategies, blending competitive compensation with automation and workflow enhancements. Leaders are also re-evaluating workload and role design to ensure long-term workforce sustainability, moving beyond just salary increases.

CVS Health reported a significant financial surge in its second quarter, with net income nearly tripling to $2.9 billion. This strong performance is largely attributed to improved cost management within its Aetna health plans, evidenced by a reduced medical benefits ratio of 87.4%, down from 89% in the prior year. CEO David Joyner cited technology-powered care engagement, leading to a second consecutive raise in diluted earnings per share guidance to $6.84-$7.04. Medical benefits ratio improvement stems from better government business performance and the absence of a previous premium deficiency reserve. Despite exiting the individual ACA market, CVS's healthcare benefits segment saw revenues grow 3.5% to $37.5 billion, contributing to overall total revenues of $106 billion, a 7% increase across all operating segments.

Major Medicare Advantage insurer Humana is withdrawing from certain markets for 2027, a move expected to be mirrored by other companies facing rising medical expenses.

Health insurer Oscar Health reported a strong second quarter, achieving a $361 million profit and over $1 billion in net income for the first half of the year. This financial success follows a 70% revenue increase to $4.9 billion and a significant rise in health plan members to 2.9 million. Under CEO Mark Bertolini, Oscar has effectively navigated the Affordable Care Act's individual market, even as major competitors like Aetna and Cigna announce their exits. The company attributes its improved performance to disciplined pricing and robust cost control, evidenced by a medical loss ratio dropping to 79.2%. Oscar remains optimistic about the individual market's future, anticipating continued profitable growth.